12 July 2021 : Clinical Research
Characteristics and Related Factors of High-Risk Human Papillomavirus Infection in Pregnant Women
Yingying Chen12ABCDEF, Jie Dong2BF, Boliang Chu2BD, Xiaoxing Zhang2BC, Xiaofang Ru2B, Yun Chen2B, Yunyan Chen2B, Xiaodong Cheng1A*DOI: 10.12659/MSM.929100
Med Sci Monit 2021; 27:e929100
Table 5 The influence of vaginal secretion infection on high-risk human papillomavirus infection in pregnant women.
| Vaginal discharge examination | Total | hr-HPV (−) | hr-HPV(+) | hr-HPV positive rate | Non-HPV16 or 18/45 positive rate | |||
|---|---|---|---|---|---|---|---|---|
| HPV16, 18/45(−) | HPV16(+)HPV18/45(−) | HPV16(−)HPV18/45(+) | HPV16(+)HPV18/45(+) | |||||
| No co-infection | 1677 | 1469 | 154 | 43 | 9 | 2 | 12.4% | 9.2% |
| VVC | 51 | 37 | 9 | 3 | 2 | 0 | ||
| BV | 35 | 21 | 8 | 4 | 1 | 1 | ||
| TV | 7 | 4 | 1 | 2 | 0 | 0 | ||
| VVC+BV | 1 | 0 | 1 | 0 | 0 | 0 | ||
| BV+TV | 3 | 1 | 2 | 0 | 0 | 0 | ||
| Total co-infected persons | 97 | 63 | 21 | 9 | 3 | 1 | 35.1% | 21.6% |
| χ | 39.926 | 16.027 | ||||||
| 0.000 | 0.000 | |||||||